• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    FDA Rejects Astellas’ Effort to Extend Eye Drug Izervay Use

    ENPTS

    US FDA declines to approve Astellas` gastric cancer drug

    REUTERS

    Drug makers pay $67m for misleading docs about cancer drug survival data

    STAT

    District Court Rules for FDA in Battle Over the Scope of 3-Year Exclusivity in the Context of Dueling Tacrolimus NDAs

    FDA LAW BLOG

    Astellas’ Xtandi cancer drug rejected by NICE

    PM LIVE

    FDA Written Request for Erlotinib

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.